Home / Current Issue / Paper 1706413
Biostatistics for Predicting Health Disparities in Infectious Disease Outcomes, Using Real-world Evidence and Public Health Intervention Data
Subject area: Biological & Medical Sciences · Area of research: Fisheries and Aquaculture
Abstract
This review explores emerging biostatistical methods, the integration of machine learning (ML) and advanced analytics, and the role of big data and artificial intelligence (AI) in addressing health disparities in public health. It highlights the growing importance of Bayesian models and ML algorithms for predicting infectious disease outcomes and stratifying populations by social determinants of health. The review accentuates the potential of AI in precision public health, with applications ranging from real-time disease surveillance to the development of personalized interventions. However, it also emphasizes the ethical challenges and biases associated with AI and ML, particularly in marginalized populations. Future research recommendations focus on developing ethical frameworks, improving the representativeness of training data, and optimizing the use of real-world evidence (RWE) in public health. By combining traditional biostatistical approaches with modern AI-driven tools, this review outlines a path toward more accurate and equitable health outcome predictions, ultimately contributing to the reduction of health disparities on a global scale.
Keywords
Biostatistical methods, Machine learning, Health disparities, Artificial intelligence, Real-world evidence
References
[1] Aboi, E. J. (2024). Religious, ethnic and regional identities in Nigerian politics: a shared interest theory. African Identities, 1-18.
[2] Ahmed, H., Hamisu, A. W., Craig, K. T., Mkanda, P., & Mahoney, F. (2020). Polio eradication in Nigeria: A review. Vaccine, 38(30), pp. 4638-4643.
[3] Andre, F. E., Booy, R., Bock, H. L., Clemens, J., Datta, S. K., John, T. J., Lee, B. W., Lolekha, S., Peltola, H., Santosham, M., & Schmitt, H. J. (2008). Vaccination greatly reduces disease, disability, death and inequity worldwide. Bulletin of the World Health Organization, 86(2), pp. 140-146.
[4] ArborAdmin. (2021). 9 ways real-world evidence is changing healthcare. ArborMetrix.
[5] Bambra, C., Riordan, R., Ford, J., and Matthews, F. (2020). The COVID-19 pandemic and health inequalities. Journal of Epidemiology and Community Health, 74(11), pp. 964-968.
[6] Barda, N., Riesel, D., Akriv, A., Levi, J., Finkel, U., Yona, G., Greenfeld, D., Sheiba, S., Somer, J., Bachmat, E. and Dagan, N., 2020. Developing a COVID-19 mortality risk prediction model when individual-level data are not available. Nature Communications, 11(1), pp.1-9.
[7] Bartram, J., & Cairncross, S. (2010). Hygiene, sanitation, and water: Forgotten foundations of health. *PLoS Medicine*, 7(11), e1000367.
[8] Bhutta, Z. A., & Saeed, M. A. (2008). Childhood infectious diseases: overview. International encyclopedia of public health, 620.
[9] Burgess, S., Butterworth, A. and Thompson, S.G., 2015. Mendelian randomization analysis with multiple genetic variants using summarized data. Genetic Epidemiology, 39(7), pp. 658-665.
[10] Casey, J. A., Schwartz, B. S., Stewart, W. F., & Adler, N. E. (2016). Using electronic health records for population health research: A review of methods and applications. Annual Review of Public Health, 37, pp. 61-81.
[11] Centers for Disease Control and Prevention (2019). Behavioral Risk Factor Surveillance System: Overview. CDC. https://www.cdc.gov/brfss/index.html.
[12] Christodoulou, E., Ma, J., Collins, G. S., Steyerberg, E. W., Verbakel, J. Y., and van Calster, B. (2019). A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. Journal of Clinical Epidemiology, 110, pp. 12-22.
[13] Cohen, T., Murray, M., Wallengren, K., Alvarez, G. G., Samuel, E. Y., & Wilson, D. (2020). The impact of community-based TB interventions: A statistical analysis of TB incidence trends. American Journal of Respiratory and Critical Care Medicine, 202(4), pp. 483-490.
[14] Collett, D. (2015). Modelling survival data in medical research (3rd ed.). CRC Press.
[15] Concato, J., Shah, N., & Horwitz, R. I. (2010). Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine, 342(25), pp. 1887-1892.
[16] Corrigan-Curay, J., Sacks, L., and Woodcock, J. (2018). Real-world evidence and real- world data for evaluating drug safety and effectiveness. JAMA, 320(9), pp. 867-868.
[17] DASCA. 2024 What is Statistical Modeling in Data Science.
[18] Dhillon, S. K., Ganggayah, M. D., Sinnadurai, S., Lio, P., & Taib, N. A. (2022). Theory and Practice of Integrating Machine Learning and Conventional Statistics in Medical Data Analysis.
[19] Diez Roux, A. V. (2012). Conceptual approaches to the study of health disparities. Annual Review of Public Health, 33, pp. 41-58.
[20] Dowd, J. B., Aiello, A. E., and Alley, D. E. (2009). Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the United States: NHANES III. Epidemiology and Infection, 137(1), pp. 58-65.
[21] Esteva, A., Kuprel, B., Novoa, R.A., Ko, J., Swetter, S.M., Blau, H.M., and Thrun, S., 2017. Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), pp.115-118.
[22] Farmer, P., Nizeye, B., Stulac, S., and Keshavjee, S. (2006). Structural violence and clinical medicine. PLoS Medicine, 3(10), pp. e449.
[23] Fewtrell, L., Kaufmann, R. B., Kay, D., Enanoria, W., Haller, L., & Colford Jr, J. M. (2005). Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: A systematic review and meta-analysis. The Lancet Infectious Diseases, 5(1), pp. 42-52.
[24] Galea, S., Riddle, M., and Kaplan, G. A. (2019). Causal thinking and complex system approaches in epidemiology. International Journal of Epidemiology, 48(3), pp. 666-677.
[25] Gelman, A., Carlin, J.B., Stern, H.S., Dunson, D.B., Vehtari, A. and Rubin, D.B., 2013. Bayesian data analysis. CRC press.
[26] Gustafson, P. (2010). Bayesian inference for partially identified models: exploring the limits of limited data. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 72(5), pp. 773-789.
[27] Harron, K., Dibben, C., Boyd, J., Hjern, A., Azimaee, M., Barreto, M. L., and Goldstein,
[28] H. (2017). Challenges in administrative data linkage for research. Big Data & Society, 4(2), pp. 1-12.
[29] Hernán, M. A. (2010). The hazards of hazard ratios. Epidemiology, 21(1), pp. 13-15.
[30] Hicken, M. T., Lee, H., & Hing, A. K. (2018). The weight of racism: Vigilance and racial inequalities in weight-related measures. Social Science & Medicine, 199, pp. 157-166.
[31] Hosmer, D. W., Lemeshow, S., and May, S. (2008). Applied survival analysis: regression modeling of time-to-event data (2nd ed.). John Wiley & Sons.
[32] Hosmer, D. W., Lemeshow, S., and Sturdivant, R. X. (2013). Applied logistic regression (3rd ed.). John Wiley & Sons.
[33] Idoko, D. O. Adegbaju, M. M., Nduka, I., Okereke, E. K., Agaba, J. A., & Ijiga, A. C . (2024). Enhancing early detection of pancreatic cancer by integrating AI with advanced imaging techniques. Magna Scientia Advanced Biology and Pharmacy, 2024, 12(02), 051– 083.
[34] Idoko, D. O., Mbachu, O. E., Ijiga, A. C., Okereke, E. K., Erondu, O. F., & Nduka, I. (2024). Assessing the influence of dietary patterns on preeclampsia and obesity among pregnant women in the United States. International Journal of Biological and Pharmaceutical Sciences Archive, 2024, 08(01), 085–103.
[35] Idoko, D. O., Agaba, J. A., Nduka, I., Badu, S. G., Ijiga, A. C. & Okereke, E. K, (2024). The role of HSE risk assessments in mitigating occupational hazards and infectious disease spread: A public health review. Open Access Research Journal of Biology and Pharmacy, 2024, 11(02), 011–030.
[36] Ioannidis, J. P. A. (2016). Why most clinical research is not useful. PLOS Medicine, 13(6), pp. 1-10.
[37] Karsh, B. T., Beasley, J. W., & Brown, R. L. (2010). Employed family physician satisfaction and commitment to their practice, work group, and health care organization. Health services research, 45(2), 457-475.
[38] Kawachi, I., Subramanian, S. V., and Almeida-Filho, N. (2002). A glossary for health inequalities. Journal of Epidemiology and Community Health, 56(9), pp. 647-652.
[39] Koh, H. K., Oppenheimer, S. C., Massin-Short, S. B., Emmons, K. M., Geller, A. C., and Viswanath, K. (2012). Translating research evidence into practice to reduce health disparities: a social determinants approach. American Journal of Public Health, 102(9), pp. S72-S78.
[40] Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Williams, B., Pillay, D., Noursadeghi, M., and Hughes, J. (2021). Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open, 11(7), e043828.
[41] Lu, P., Singleton, J. A., Euler, G. L., Williams, W. W., and Bridges, C. B. (2014). Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011. American Journal of Epidemiology, 180(6), pp. 599-607.
[42] Lundgren, J. D., Babiker, A. G., Gordin, F., Emery, S., Grund, B., Sharma, S., Avihingsanon, A., Cooper, D. A., Fatkenheuer, G., & Llibre, J. M. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, 373(9), pp. 795-807.
[43] Makady, A., Ham, R. T., de Boer, A., Hillege, H., Klungel, O., & Goettsch, W. (2017). Policies for use of real-world data in health technology assessment (HTA): A comparative study of six HTA agencies. Value in Health, 20(4), pp. 520-532.
[44] Marmot, M. (2005). Social determinants of health inequalities. The Lancet, 365(9464), pp. 1099-1104.
[45] Merletti, F., Galassi, C., and Spadea, T. (2011). The socioeconomic determinants of cancer. Cancer Epidemiology, 35(1), pp. S26-S33.
[46] National Academies of Sciences, Engineering, and Medicine (NASEM). (2019). Examining the impact of real-world evidence on medical product development:Proceedings of a workshop series. The National Academies Press. NASEM. 2019
[47] Neumann, P. J., Cohen, J. T., & Kim, D. D. (2021). Consideration of value-based pricing for treatments and vaccines is critical to tackle COVID-19. Health Affairs, 40(2), pp. 253- 261.
[48] Nguyen, S., Li, H., Yu, D., Gao, J., Gao, Y., Tran, H., ... & Shu, X. O. (2020). Adherence to dietary recommendations and colorectal cancer risk: results from two prospective cohort studies. International Journal of Epidemiology, 49(1), 270-280.
[49] Obermeyer, Z., Powers, B., Vogeli, C. and Mullainathan, S., 2019. Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), pp.447-453.
[50] Pelat, C., Ferguson, N. M., White, P. J., Reed, C., Finelli, L., Cauchemez, S., & Fraser, C. (2014). Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach. American journal of epidemiology, 180(10), 1036-1046.
[51] Phelan, J. C., Link, B. G., and Tehranifar, P. (2010). Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. Journal of Health and Social Behavior, 51(1_suppl), pp. S28-S40.
[52] Pocock, S. J. (2013). Clinical trials: a practical approach. John Wiley & Sons.
[53] Powers, K. A., Kretzschmar, M. E., Miller, W. C., & Cohen, M. S. (2020). Impact of early- stage HIV treatment programs in sub-Saharan Africa: A population-based evaluation of the PEPFAR initiative. AIDS, 34(11), pp. 1583-1593.
[54] Radhakrishnan, M., & Puckrein, G. (2024). Using real-world evidence to supplement randomized controlled trials and reduce health inequity.
[55] Rajkomar, A., Dean, J., and Kohane, I. (2018). Machine learning in medicine. New England Journal of Medicine, 380(14), pp. 1347-1358.
[56] Rosella, L. C., Fitzpatrick, T., Wodchis, W. P., Calzavara, A., Manson, H., and Goel, V. (2018). High-cost health care users in Ontario, Canada: demographic, socio-economic, and health status characteristics. BMC Health Services Research, 18, p. 532.
[57] Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), pp. 41-55.
[58] Rothwell, P. M. (2005). External validity of randomised controlled trials: To whom do the results of this trial apply? The Lancet, 365(9453), pp. 82-93.
[59] Rubin, D. B. (2004). Multiple imputation for nonresponse in surveys. John Wiley & Sons.
[60] Sattar, N., McInnes, I. B., and McMurray, J. J. V. (2020). Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation, 142(1), pp. 4-6.
[61] Sherman, R. E., Anderson, S. A., Dal Pan, G. J., Gray, G. W., Gross, T., Hunter, N. L., & LaVange, L. M. (2016). Real-world evidence—What is it and what can it tell us? New England Journal of Medicine, 375(23), pp. 2293-2297.
[62] Skarbinski, J., Rosenberg, E., Paz-Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., & Mermin, J. H. (2015). Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Internal Medicine, 175(4), pp. 588-596.
[63] Snyder, J. M., Pawloski, J., & Poisson, L. (2020). Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.
[64] Suárez, P. G., Watt, C. J., Alarcón, E., Portocarrero, J., Zavala, D., Canales, R., LaForce, F. M., Dye, C., & Raviglione, M. C. (2011). The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. Journal of Infectious Diseases, 184(4), pp. 473- 478.
[65] Subramanian, S. V., and Kawachi, I. (2004). Income inequality and health: what have we learned so far? Epidemiologic Reviews, 26(1), pp. 78-91.
[66] Sullivan, L. M. (2012). Essentials of biostatistics in public health (2nd ed.). Jones & Bartlett Learning.
[67] Tai, D. B., Shah, A., Doubeni, C. A., Sia, I. G., & Wieland, M. L. (2021). The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States. Clinical Infectious Diseases, 72(4), pp. 703-706.
[68] Topol, E.J., 2019. High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), pp.44-56.
[69] Vandenbroucke, J. P., & Pearce, N. (2012). Case-control studies: Basic concepts. International Journal of Epidemiology, 41(5), pp. 1480-1489.
[70] Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., and Egger, M. (2007). Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Medicine, 4(10), e297.
[71] VanderWeele, T. J., & Robinson, W. R. (2014). On causal interpretation of race in regressions adjusting for confounding and mediating variables. Epidemiology, 25(4), pp. 473-484.
[72] Vokinger, K.N., Feuerriegel, S., and Kesselheim, A.S., 2021. Mitigating bias in machine learning for medicine. Communications Medicine, 1(1), pp.1-3.
[73] World Health Organization (WHO) (2021). World malaria report 2021. World Health Organization.
[74] World Health Organization. (2022). WHO Coronavirus (COVID-19) Dashboard.
[75] Wu, Y., Schuster, M., Chen, Z., Le, Q.V., Norouzi, M., Macherey, W., Krikun, M., Cao, Y., Gao, Q., Macherey, K. and Klingner, J., 2016. Google's neural machine translation system: Bridging the gap between human and machine translation. Communications of the ACM, 63(7), pp.176-184.
How to cite this paper
@article{1706413,
author = {David Oche Idoko, Okoroji Emmanuel Mbachu, Idayat Ninilola Ololade Babalola, Erondu Okechukwu Felix, Oluwayemisi Dada-Abidakun; Yewande Adeyeye},
title = {Biostatistics for Predicting Health Disparities in Infectious Disease Outcomes, Using Real-world Evidence and Public Health Intervention Data},
journal = {Iconic Research And Engineering Journals},
year = {2024},
volume = {8},
number = {4},
pages = {319-344},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1706413.pdf},
abstract = {This review explores emerging biostatistical methods, the integration of machine learning (ML) and advanced analytics, and the role of big data and artificial intelligence (AI) in addressing health disparities in public health. It highlights the growing importance of Bayesian models and ML algorithms for predicting infectious disease outcomes and stratifying populations by social determinants of health. The review accentuates the potential of AI in precision public health, with applications ranging from real-time disease surveillance to the development of personalized interventions. However, it also emphasizes the ethical challenges and biases associated with AI and ML, particularly in marginalized populations. Future research recommendations focus on developing ethical frameworks, improving the representativeness of training data, and optimizing the use of real-world evidence (RWE) in public health. By combining traditional biostatistical approaches with modern AI-driven tools, this review outlines a path toward more accurate and equitable health outcome predictions, ultimately contributing to the reduction of health disparities on a global scale.},
keywords = {Biostatistical methods, Machine learning, Health disparities, Artificial intelligence, Real-world evidence},
month = {October},
}